Maze Therapeutics MAZE
NASDAQ MAZE
$36.81 +1.36 (+3.84%)
As of: Nov 11, 2026 · 10:52 AM EST

Maze Therapeutics (MAZE) Long-Term Investments (2025 - 2026)

Updated

Maze Therapeutics (MAZE) posted Long-Term Investments of $83.82 million for Q2 2026, up 694.1% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Long-Term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics' Long-Term Investments came in at $18.11 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Maze Therapeutics 2.00 Bn 506.07 Mn - 87.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 87.32 Mn
Jun 30, 2026 83.82 Mn
Mar 31, 2026 10.56 Mn
Dec 31, 2025 18.11 Mn
API Access

Maze Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=MAZE&period=max&api_key=YOUR_API_KEY